Investigation of Barriers to Access Hepatitis B Testing among Secondary School Students after a Peer Education Study in Jos, Nigeria
A high average
prevalence rate of 11-13.7% % for viral hepatitis B exists in Nigeria. This
study examined the barriers to access hepatitis B virus (HBV) testing among
senior secondary school students in six public day secondary schools located in
Jos South Local Government Area, Plateau state. It also related the beliefs
held on HBV in relation to barriers for access to HBV testing following the
impact of a peer education intervention.
quasi-experimental study was carried out on six hundred students selected by a
multistage sampling technique. A pre-tested formal self-administered
questionnaire (SAQ) was used to collect data pre and twelve weeks post
intervention. Chi- square and students t-test was done to compare intervention
and control groups on outcome variables. Results showed the age distribution of
the respondents was 10-24 years with majority of respondents (86.7%) in the age
group 15-19 years. The most frequent reason got as a barrier for accessing HBV
test was ‘I did not know a HBV test was available’. This was related to the
belief that ‘parents were keen to agree’ for the student to have a hepatitis B
test done as shown by the chi-square test performed post intervention between
intervention and control group using chi-square test was found. There was no
significant difference in the belief by students: I have not done a HBV test.
However, the students tested for HBV were only from the
intervention group showing access to HBV testing was enhanced by its direct
availability in the intervention schools. This is in line with the barrier by
students that they did not have availability of HBV test. A prevalence rate of 9.1% was found on HBV testing among the
Keywords: Hepatitis B
testing, secondary school, student, barrier, access, prevalence.
.Aziz Ali, S., Suhail, N., & Ali, A.
S. (2016). Cultural and Social Barriers in increased burden of hepatitis B in
Pakistan: Literature review. Journal of
Infectious Diseases and Diagnosis, 1(2), 105. Retrieved from https://www.omicsonline.org/open-access/role-of-cultural-and-social-barriers-in-increased-burden-of-hepatitis-b-inpakistan-literature-review-jidd-100105.php?aid=75328.
.Bequelin, C., Fatou, F., Seydi, M.,
& Wandele, G. (2018). The current situation and challenges of screening for
and treating hepatitis B in sub-Saharan Africa. Expert review of gastroenterology & Hepatology, 12(6).
Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154452/.
.Center for Disease Control
and Prevention. (2018). Hepatitis B: Testing and vaccination. Retrieved from http://www.immunize.org/catg.d/p2110.pdf.
.Chingle, M. P., Osagie,
I.A., Adams, H., Gwomson, D., Emeribe, N., & Zoakah, A.I. (2017). Risk
perception of hepatitis B infection and uptake of hepatitis B vaccine among
students of tertiary institution in Jos. Annals of African
Medicine, 16(2), 59-64. Retrieved from http://www.annalsafrmed.org/article.asp?issn=1596-3519;year=2017;volume=16;issue=2;spage=59;epage=64;aulast=Chingle.
.Federal Ministry of Health (2013). National Training
Manual on Peer-to-Peer Youth health education. Growing girls and women in
Nigeria (G-Win Project). 1-142. Retrieved from http://www.health.gov.ng/doc/TrgManualP2PYHE.pdf.
.Giles-Vernick, T., Hejoaka,
F., Sanou, A., Shimakawa, Y., Bamba, I., & Traore, A. (2016). Barriers to
linkage to care for hepatitis B virus infection: a qualitative analysis in
burkina faso, west Africa. American
Journal of Tropical Medicine and Hygiene, 95(6). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154452/.
.Hu, K. Q., Pan, C. Q., & Goodwin, D. (2011). Barriers
to screening for hepatitis B virus infection in Asian Americans. Digestive Diseases and Sciences, 56(11),
3163-71. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21861105.
.Ikobah, J., Okpara, H., Elemi, I., Ogarepe, Y., Udoh, E.,
& Ekanem, E. (2016). The prevalence of hepatitis B virus infection in
Nigerian children prior to vaccine introduction into the National Programme on
Immunization schedule. Pan African
Medical Journal, 23 (128). doi: 10.11604/pamj.2016.23.128.8756. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885699/.
.National AIDS/STIs Control Program (2016). Introduction.
Guidelines for the Prevention, Treatment and Care of Viral Hepatitis in
Nigeria. Federal Ministry of Health. p 1-30.
. Spearman, C.W., Afihene, M., Ally, R., Apica,
B., Awuku, Y., Cunha, L., Dusheiko, G., Gogela, N., Kassianides, C., Kew, M.,
Lam, P., Lesi, O., Lohoues-Kouacou, M., Mbaye, S., Musabeyezu, E., Musau, B.,
Ojo, O., Rwegasha, J., Scholz, B., Shewaye,. A.B., Tzeuton, C., Sonderup, M.W.
(2017). Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030
elimination targets. The Lancet
Gastroenterology & Hepatology, 2(12), 900-909. doi: https://doi.org/10.1016/S2468-1253(17)30295-9.
. Umego, C. F., Mboto, C. I.,
Mbim, E. N., Edet, U. O., George, U. E., Tarh, J.E. (2018). Epidemiology of
hepatitis B virus infection in South South Nigeria: A review. Retrieved
. World Health Organization
(2018). Global Health Sector Strategy on Viral Hepatitis 2016–2021: Towards
Ending Viral Hepatitis 2016. Retrieved from http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/ ID: 101666147.